Role of cetuximab in first-line treatment of metastatic colorectal cancer. [electronic resource]
Producer: 20150413Description: 4208-19 p. digitalISSN:- 2219-2840
- Antibodies, Monoclonal, Humanized -- therapeutic use
- Antineoplastic Agents -- therapeutic use
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Biomarkers, Tumor -- metabolism
- Camptothecin -- analogs & derivatives
- Cetuximab
- Clinical Trials as Topic
- Colorectal Neoplasms -- drug therapy
- ErbB Receptors -- metabolism
- Fluorouracil -- therapeutic use
- Humans
- Leucovorin -- therapeutic use
- Ligands
- Liver Neoplasms -- secondary
- Mutation
- Neoplasm Metastasis
- Organoplatinum Compounds -- therapeutic use
- Oxaliplatin
- Proto-Oncogene Proteins -- genetics
- Proto-Oncogene Proteins p21(ras)
- Treatment Outcome
- Vascular Endothelial Growth Factor A -- metabolism
- ras Proteins -- genetics
No physical items for this record
Publication Type: Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.